BALYASNY ASSET MANAGEMENT L.P. - CANTEL MEDICAL CORP ownership

CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 214 filers reported holding CANTEL MEDICAL CORP in Q2 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of CANTEL MEDICAL CORP
ValueSharesWeighting
Q1 2021$531,000
-95.0%
6,647
-97.2%
0.00%
-96.1%
Q3 2020$10,535,000
+38.3%
239,767
+39.2%
0.08%
+16.7%
Q2 2020$7,620,000
+643.4%
172,273
+1091.5%
0.07%
+1000.0%
Q4 2019$1,025,000
+327.1%
14,458
+350.0%
0.01%
+200.0%
Q3 2019$240,000
-74.5%
3,213
-66.5%
0.00%
-50.0%
Q2 2018$943,0009,5860.00%
Other shareholders
CANTEL MEDICAL CORP shareholders Q2 2020
NameSharesValueWeighting ↓
DIKER MANAGEMENT LLC 1,383,325$136,064,00048.67%
Brown Capital Management 3,345,000$329,014,0003.38%
Kimelman & Baird, LLC 206,142$20,276,0002.66%
Conestoga Capital Advisors, LLC 690,673$67,935,0002.19%
WASATCH ADVISORS LP 1,772,992$174,391,0002.10%
Ranger Investment Management 280,989$27,638,0001.93%
Freedom Day Solutions, LLC 21,938$2,158,0001.76%
CAPITAL INSIGHT PARTNERS, LLC 17,853$1,756,0001.44%
Geller Advisors LLC 22,700$2,233,0000.97%
Sapphire Star Partners LP 8,607$846,0000.87%
View complete list of CANTEL MEDICAL CORP shareholders